Heron Therapeutics, Inc.

Q4 2022 vs. Q4 2025 13F Holders

Period
Q4 2022
Q4 2025
Num holders
184
175
Total reported value, excl. options
$296 M
$206 M
Total shares, excl. options
118,420,265
155,582,229
Manager Q4 2022
Shares
Q4 2025
Shares
Diff Chg %